Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole

Taghavi, S. A.; Ghasedi, M.; Saberi-Firoozi, M.; Alizadeh-Naeeni, M.; Bagheri-Lankarani, K.; Kaviani, M. J.; Hamidpour, L.
August 2005
Gut;Aug2005, Vol. 54 Issue 8, p1067
Academic Journal
Background: Twenty four hour oesophageal pH monitoring is frequently used to quantify the association between a patient's symptom and gastro-oesophageal reflux. Three indices (symptom association probability (SAP), symptom index (SI), and symptom sensitivity index (SSI)) are used to quantify and establish this relation. Aims: The aim of the present study was to compare these indices against the omeprazole test (OT) as an objective indicator of reflux induced symptoms. Methods: Fifty two patients with a predominant symptom of heartburn were enrolled from gastroenterology and primary care clinics. Baseline symptom score was calculated at the fist visit. All patients underwent 24 hour oesophageal pH monitoring, and symptom-reflux association indices were calculated. All patients were placed on high dose omeprazole (40 mg in the morning, 20 mg at night) after completion of pH monitoring and symptom score was recorded again after one week. Results: Thirty eight patients completed the study. All three indices were significantly related to each other (p<0.001). SAP and SSI (with a new cut off of 1.3, but not with the commonly used 5%) had statistically significant relations with OT (p<0.05 for both). SSI had the highest positive and negative predictive values and sensitivity. The specificity of SSI and SAP was equal and lower than SI. Areas under the receiver operating characteristic (ROC) curve for the three indices were not significantly different from each other or from a hypothetical non-discriminating test. Per cent time pH <4, sex, and age had no relation to OT and no effect on its correlation with association indices. No cut off point could be found at which the results of SI could be related significantly to the OT results. Conclusion: SAP and SSI are significantly related to symptomatic response to high dose omeprazole; however, they are far from perfect, with a significant number of discordant cases as well as relatively small areas under the ROC curves. We suggest that the new cut off of 1.3 be used for SSI in the future. Further research is needed to identify possible methods to improve the discrimination power of these indices or to identify possible patient characteristics that may affect this relation.


Related Articles

  • Omeprazole Versus High-Dose Ranitidine in Mild Gastroesophageal Reflux Disease: Short- and Long-Term Treatment. Fesien, Henk P. M.; Schenk, Ed; Gie Tan; Snel, Pleun; Nelis, Frits // American Journal of Gastroenterology;Apr1999, Vol. 94 Issue 4, p931 

    OBJECTIVE: Patients with reflux esophagitis suffer from a chronic condition that may cause considerable discomfort because of recurrent symptoms and diminished quality of life. This study was designed to evaluate acute and long-term treatment comparing standard doses of omeprazole and high-dose...

  • Selection of Patients for Successful Maintenance Treatment of Esophagitis With Low-Dose Omeprazole: Use of 24-Hour Gastric pH Monitoring. Ladas, Spiros D.; Tassios, Pericles S.; Raptis, Sotirios A. // American Journal of Gastroenterology;Feb2000, Vol. 95 Issue 2, p374 

    OBJECTIVE: Treating patients with erosive esophagitis and maintaining remission in a cost-effective fashion is a desirable goal in clinical practice. There are no established criteria to identify patients with healed esophagitis who will subsequently remain in remission with low-dose omeprazole...

  • Natural Course of Gastroesophageal Reflux Disease: 17-22 Year Follow-Up of 60 Patients. Isolauri, Jouko; Luostarinen, Markku; Isolauri, Erika; Reinikainen, Pekka; Viljakka, Mikko; Keyriläinen, Olavi // American Journal of Gastroenterology;Jan1997, Vol. 92 Issue 1, p37 

    Objective: To elucidate the long-term course of conservatively managed gastroesophageal reflux disease without H2-antagonists or omeprazole. Methods: Design: Clinical trial, uncontrolled. Setting: Gastroenterological outpatient department of a teaching hospital. Patients: Sixty of 87 patients...

  • Effect of Omeprazole and High Doses of Ranitidine on Gastric Acidity and Gastroesophageal Reflux in Patients with Moderate-Severe Esophagitis. Fiorucci, Stefano; Santucci, Luca; Morelli, Antonio // American Journal of Gastroenterology;Nov1990, Vol. 85 Issue 11, p1458 

    Thirty to fifty percent of patients with reflux esophagitis fail to heal after treatment with conventional doses of 112-receptor antagonists, whereas omeprazole administration induces more than 90% healing. To investigate the effect of omeprazole and higher-than-presently-recommended doses of...

  • OMEPRAZOLE OR RANITIDINE FOR INTERMITTENT TREATMENT OF GERD? Salzberg, Sarah A.; Newton, Warren P. // Journal of Family Practice;May99, Vol. 48 Issue 5, p332 

    The article presents information on a study that examines the suitability of using omeprazole or ranitidine for the intermittent treatment of gastroesophageal reflux disease (GERD). GERD is a common diagnosis in primary care, but optimal management is not well defined. Continuous treatment with...

  • Assessing Symptoms in Gastroesophageal Reflux Disease: How Well Do Clinicians' Assessments Agree with Those of Their Patients? McColl, Elaine; Junghard, Ola; Wiklund, Ingela; Revicki, Dennis A. // American Journal of Gastroenterology;Jan2005, Vol. 100 Issue 1, p11 

    OBJECTIVES: This study aimed to determine the extent of agreement between clinicians and patients regarding assessments of reflux symptom severity in patients with gastroesophageal reflux disease.METHODS: Data were analyzed from four randomized clinical trials involving 2,674 patients treated...

  • Reflux Esophagitis: Healed! Now What? Romero, Yvonne; Egan, Laurence J.; Muray, Joseph A. // American Journal of Gastroenterology;Feb2000, Vol. 95 Issue 2, p337 

    Offers observation on reflux esophagitis. Number of Americans who experience heartburn annually; Information on proton pump inhibitor; Primary inactivation pathway for omeprazole.

  • THE AMBULATORY pH STUDY IS NORMAL, BUT THE PATIENT IS NOT - THE IMPORTANCE OF THE SYMPTOMS INDEX. Katz, Philip; Johnson, David // American Journal of Gastroenterology;Jan1998, Vol. 93 Issue 1, p129 

    Comments on a study of ambulatory pH monitoring in patients with gastroseophageal reflux. Importance of the prevalence of the acid-sensitive esophagus in patients with heartburn and regurgitation; Information on additional reflux events in the previous minutes before chest pain; Efficacy of...

  • COMMENTARY: Esomeprazole was not better than omeprazole for resolving heartburn in endoscopy-negative reflux disease. Chiba, Naoki // ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p6 

    The article reports that esomeprazole was not better than omeprazole for resolving heartburn in endoscopy-negative reflux disease. If heartburn is predominant, these patients are considered to have gastroesophageal reflux disease (GERD). After endoscopy, these patients can be divided into those...


Read the Article


Sign out of this library

Other Topics